Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.43 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | AMY2A | P04746 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LRAT | O95237 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | FGF1 | P05230 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17948319 | 1.00 | AMY1A (0.43) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL17948325 | 1.00 | AMY1A (0.43) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL17948327 | 1.00 | AMY1A (0.43) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL17948402 | 1.00 | AMY1A (0.43) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL17948322 | 1.00 | AMY1A (0.43) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL17948390 | 1.00 | AMY1A (0.43) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL17948293 | 1.00 | AMY1A (0.43) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL12787180 | 0.91 | LGALS8 (0.52) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL12787186 | 0.91 | LGALS8 (0.52) | AMY1ALGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL12787189 | 0.91 | LGALS8 (0.52) | AMY1ALGALS8LGALS3LGALS4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160215033-A1 | Granulocyte Macrophage Colony-Stimulating Factor Compositions | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160215033-A1 | Granulocyte Macrophage Colony-Stimulating Factor Compositions | CSF3R, CSF1R, GMFG | AMY1A 3076/4885LGALS8 121/4885LGALS3 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.